The new rules on the medicines interchangeability No. 1360 (hereinafter – the Rules) enacted by the Russian Government have entered into force on 9 September 2020.

The new review of the most notable patents disputes in Life Sciences in EAEU, CIS and Eastern Europe.

• pdf, 295.29 kb

August 27th, 2020 Lidings Managing Partner Andrey Zelenin and Associate Julia Kuzmenko will run a special master class dedicated to Legal Advice to Life Sciences Companies: Lawyer’s Knowledge and Capabilities as a part of the two-day educational programme of the Lomonosov Moscow State University entitled Summer Masters’ School (SMS). Becoming traditional this summer students’ event is scheduled on August 27–28 and this year will run in a Zoom format.

The coronavirus outbreak (COVID-19) served as a trigger for a targeted effort to assess and manage the possible effects of it. The Russian Government continues to update the measures taken or introduce new ones, trying to act ahead of the possible adverse consequences. Our lawyers are closely monitoring the situation, watching out for the new measures introduced in relation to the coronavirus.
We offer overview of key legislative changes and recommendations for business in the current pandemic.

Specification of the information about the license is not required directly in the advertising of medical activities that are subject to licensing. Verification of the presence of relevant documents is carried out at the request of the advertising distributor in accordance with article 13 of the Law on advertising. The advertiser, in turn, shall provide reports, including information about the availability of a license, mandatory certification and state registration.

June 26th 2020 Julia Kuzmenko, Associate in Lidings’ Corporate and M&A practice will run an online-seminar on the legal aspects of telemedicine, organized by Sobytie conference center.

16 May 2020 the Russian Government enacted the rules on online sales and delivery of medicines (the Rules). According to the Rules, online sales of medicines are allowed. The exceptions are: RX medicines, narcotic and psychotropic medicines, and medicines containing more than 25% ethyl alcohol.

This refers to the fast track registration and conduct of clinical trials, which is valid until January 1, 2021 and is worked out for medical drugs potentially effective in the fight against COVID-19.

May 27th 2020 Julia Kuzmenko, Associate in Lidings’ Corporate and M&A practice, will take part in ONLINE PHARMA ADVANCE CONFERENCE organized by Business Summit of Future.